Inhibition of Murine AIDS by Alternate Administration of Azidothymidine and Fludarabine Monophosphate
Rapid Communication: Efavirenz- and Adefovir Dipivoxil-Based Salvage Therapy in Highly Treatment-Experienced Patients: Clinical and Genotypic Predictors of Virologic Response
Phase II Placebo-Controlled Trial of Fozivudine Tidoxil for HIV Infection: Pharmacokinetics, Tolerability, and Efficacy
Incidence of Adverse Reactions in HIV Patients Treated With Protease Inhibitors: A Cohort Study
Randomized Trial of Vitamin Supplements in Relation to Vertical Transmission of HIV-1 in Tanzania
Dual Nucleoside Regimens in Nonadvanced HIV Infection: Prospective Follow-Up of 130 Patients, Aquitaine Cohort, 1996 to 1998
Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998
Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men
Correlates of Risky Behaviors Among Young and Older Men Having Sexual Relations With Men in Montréal, Québec, Canada
Emergence of Zidovudine Resistance in HIV-Infected Patients Receiving Stavudine
Evaluation of Three Rapid/Simple Tests for Detection of HIV-2 Antibodies*
Persistent Human Herpesvirus 8 Viremia Associated With Coinfection With Human T-Cell Lymphotropic Virus Type I and Myelofibrosis
HARNESSING THE IMMUNE SYSTEM IN THE FIGHT AGAINST AIDS : ABSTRACT S1
INTERNATIONAL COLLABORATION ON HIV AND CANCER : ABSTRACT S2
The National AIDS-Cancer Match Registry (NACMR) : ABSTRACT S3
RISK FOR HEPATOCELLULAR CARCINOMA (HCC) AND NON-HODGKIN'S LYMPHOMA (NHL) AMONG HIV-INFECTED ADULTS. : ABSTRACT S4
HUMAN PAPILLOMAVIRUS-ASSOCIATED ANOGENITAL CANCERS IN PATIENTS WITH HIV INFECTION AND AIDS : ABSTRACT S5
IN VITRO TRANSMISSION AND PROPAGATION OF KSHV/HHV8 IN ENDOTHELIAL CELLS. : ABSTRACT S6
TRANSMISSION OF HUMAN HERPESVIRUS 8 (HHV-8) AMONG HOMOSEXUAL MEN : ABSTRACT S7
NATURAL HISTORY OF HUMAN HERPESVIRUS 8 INFECTION IN AN ENDEMIC POPULATION: EVIDENCE FOR MOTHER-CHILD AND SIB-SIB TRANSMISSION. : ABSTRACT S8
Evidence for heterosexual transmission of HHV8 in (South) Africa : ABSTRACT S9
HHV-8: Anatomic Sites, Shedding Patterns, Behavioral and Biological Risk Factors for Transmission. : ABSTRACT S10
In vitro infection of primary human endothelial, epidermal and lymphoid cells by KSHV/HHV-8. : ABSTRACT S11
HHV8 INFECTION AND GROWTH REGULATION OF DERMAL MICROVASCULAR ENDOTHELIAL CELLS. : ABSTRACT S12
TRANSLATIONAL DEVELOPMENT OF VACCINES AGAINST B-CELL MALIGNANCIES : ABSTRACT S13
EPSTEIN-BARR VIRUS USURPS TUMOR NECROSIS FACTOR AND NOTCH RECEPTOR PATHWAYS TO CAUSE LYMPHOCYTE PROLIFERATION AND SURVIVAL. : ABSTRACT S14
INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA: A REVIEW OF THE EINSTEIN, AVIANO, AND ECOG EXPERIENCE IN 182 PATIENTS. : ABSTRACT S15
DOSE-ADJUSTED EPOCH CHEMOTHERAPY (CT) WITH SUSPENSION OF ANTIRETROVIRAL THERAPY (ART) FOR HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (HIV-NHL) : ABSTRACT S16
DOSE ADJUSTED TREATMENT IN AIDS-RELATED LYMPHOMA (NHL & HD). : ABSTRACT S17
NON-MYELOABLATIVE BONE MARROW TRANSPLANTATION IN THE TREATMENT OF REFRACTORY LYMPHOMAS : ABSTRACT S18
TREATMENT OF AIDS LYMPHOMA WITH HIGH-DOSE CHEMOTHERAPY AND GENETICALLY MODIFIED STEM CELLS: A MODEL FOR EVALUATION OF GENE THERAPY. : ABSTRACT S19
Viral Infection and Malignancy in the Organ Transplant Recipient : ABSTRACT S20
RISK ESTIMATES AND SUBSEQUENT THERAPEUTIC STRATEGIES IN POSTTRANSPLANT KAPOSI'S SARCOMA : ABSTRACT S21
EVIDENCE FOR REACTIVATION OF HHV-8 AMONG SOLID ORGAN BUT NOT BONE MARROW TRANSPLANT PATIENTS. : ABSTRACT S22
PREVALENCE OF ANTIBODIES TO HUMAN HERPESVIRUS 8 (HHV8) IN SAUDI ARABIAN PATIENTS WITH AND WITHOUT RENAL FAILURE. : ABSTRACT S23
NON MALIGNANT DISEASE ASSOCIATED WITH HHV-8 INFECTION IN PERIPHERAL BLOOD STEM CELL (PBSC) AND RENAL TRANSPLANT PATIENTS FROM ITALY. : ABSTRACT S24
MONITORING ACTIVITY IN LESIONS OF KAPOSI'S SARCOMA USING INFRA-RED IMAGES : ABSTRACT S25
HPV in HIV positive adolescents : ABSTRACT S26
National linkage of HIV, AIDS and cancer incidence data : ABSTRACT 1
The spectrum of HIV-1 related cancers in South Africa : ABSTRACT 2
NON-MYELOABLATIVE ALLOGENEIC TRANSPLANTATION OF GENETICALLY MODIFIED PBSCS FOR HEMATOLOGIC MALIGNANCIES IN HIV + ADULTS. : ABSTRACT 3
EVIDENCE OF BLOOD-BORNE TRANSMISSION OF HUMAN HERPESVIRUS 8 (HHV-8) AMONG WOMEN WITH HIV RISK BEHAVIORS. : ABSTRACT 4
MIXED LATENT AND LYTIC CYCLE INFECTION OF PRIMARY HUMAN DERMAL MICROVASCULAR ENDOTHELIAL CELLS WITH KSHV/HHV8 DERIVED FROM THE JCS1 PEL CELL LINE : ABSTRACT 5
HHV8/KSHV REGULATION OF ENDOTHELIAL CELL GROWTH AND DIFFERENTIATION PATHWAYS. : ABSTRACT 6
Characterization of Hematopoietic Progenitor Cells following in vitro infection by Kaposi's Sarcoma-associated Herpesvirus (KSHV/HHV-8). : ABSTRACT 7
INFECTION OF ENDOTHELIAL CELLS WITH HUMAN HERPESVIRUS 8 LEADS TO INDUCTION OF CELLULAR ANTIVIRAL GENES : ABSTRACT 8
WITHDRAWN : ABSTRACT 9
THE KSHV LATENCY-ASSOCIATED NUCLEAR ANTIGEN MEDIATES EPISOME PERSISTENCE THROUGH CIS-ACTING KSHV TERMINAL REPEAT (TR) DNA AND SPECIFICALLY BINDS TR SEQUENCE : ABSTRACT 10
DETERMINATION OF HIV-1 SEROTYPE BY ELISA V3-LOOP : ABSTRACT 11
The serologic study on the origin of HIV blood spread. : ABSTRACT 12
THE TITER OF SERUM PROTEINS RELATED TO THE T CELL RECEPTOR IS ELEVATED IN THE SERA OF HIV+, SYMPTOMATIC PATIENTS. : ABSTRACT 13
MIP-1β INDUCED HETERELOGOUS DESENSITIZATION OF CXCR4 MEDIATED SIGNALING ON EARLY LINEAGE B CELLS IN HUMAN BONE MARROW. : ABSTRACT 14
TISSUE AND BIOLOGICAL FLUIDS BANKS OF HIV-RELATED MALIGNANCIES : ABSTRACT 15
APPLICATION OF THE TISSUE MICROARRAY (TMA) METHOD BY THE MIDREGION AIDS AND CANCER SPECIMEN BANK (ACSB) TO PREPARE STUDY SETS FROM HIV INFECTED AND CONTROL TISSUES : ABSTRACT 16
MALIGNANT TUMORS IN RENAL TRANSPLANTATION PATIENTS (MTRTP). : ABSTRACT 17
AIDS RELATED MALIGNANCIES: CLINICAL AND EPIDEMIOLOGIC FEATURES IN VENEZUELAN PATIENTS. : ABSTRACT 18
HIGH PREVALENCE OF HUMAN HERPESVIRUS 8 (HHV-8) SEROPOSITIVITY AMONG HIV-NEGATIVE ETHIOPIAN IMMIGRANTS TO ISRAEL DESPITE ABSENCE OF KAPOSI'S SARCOMA. : ABSTRACT 19
HERPES VIRUS 8 INFECTION AMONG WOMEN WITH DIFFERENT SEXUAL BEHAVIOR : ABSTRACT 20
The serological prevalence of Kaposi's sarcoma-associated herpesvirus in Chinese drug users and normal blood donors. : ABSTRACT 21
INDUCTION OF HHV-8 LYTIC CYCLE REPLICATION BY HIV-1 INFECTED T-CELLS. : ABSTRACT 22
INDUCTION OF INFLAMMATORY CYTOKINES CORRELATES WITH HUMAN KAPOSI'S SARCOMA CELL-INDUCED TUMORS IN HIV-1 TAT-EXPRESSING TRANSGENIC MICE. : ABSTRACT 23
HUMAN HERPESVIRUS-8 (HHV-8)-ENCODED INTERLEUKIN 6 (vIL6) STIMULATES B LYMPHOCYTES AND KAPOSI'S SARCOMA CELLS THAT ARE UNRESPONSIVE TO HUMAN IL6 (hIL6). : ABSTRACT 24
A NEW PRIMARY EFFUSION LYMPHOMA (PEL) - DERIVED CELL LINE YIELDS HIGHLY INFECTIOUS KAPOSI'S SARCOMA HERPESVIRUS SUPERNATANT : ABSTRACT 25
INTRAFAMILIAL TRANSMISSION OF HUMAN HERPESVIRUS 8. : ABSTRACT 26
CAN HHV-8 BE TRANSMITTED PERINATALLY? : ABSTRACT 27
A LONGITUDINAL STUDY OF HHV-8 VERTICAL TRANSMISSION IN SARDINIA : ABSTRACT 28
FAS LIGAND BASED GENE THERAPY FOR KS LESIONS. : ABSTRACT 29
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS ACTIVE AS ANTI-KAPOSI'S SARCOMA (KS) THERAPY: RESULTS OF A TRIAL IN 53 PATIENTS (PTS) : ABSTRACT 30
Efficacy and safety of long-term alitretinoin gel (Panretin®) for cutaneous AIDS-related Kaposi's sarcoma. : ABSTRACT 31
MULTICENTER, RANDOMIZED, OPEN-LABEL PHASE II TRIAL OF TWO DOSES OF INTERFERON (IFN)-α2b WITH DIDANOSINE (ddI) IN HIV-RELATED KAPOSI'S SARCOMA: ACTG 206. : ABSTRACT 32
Phase II Study of 9-Aminocamptothecin (9AC) in Patients with AIDSrelated Kaposi's Sarcoma (KS). : ABSTRACT 33
PHASE II TRIAL OF LIPOSOMAL DAUNORUBICIN WITH CONCURRENT PROTEASE INHIBITORS IN AIDS-RELATED KAPOSI'S SARCOMA. : ABSTRACT 34
BONE MARROW TRANSPLANT (BMT) RECIPIENT POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDERS (PT-LPDs) DIFFER FROM THOSE IN SOLID ORGAN TRANSPLANT (SOT) RECIPIENTS. : ABSTRACT 35
TCL-1 ONCOPROTEIN EXPRESSION AND VH GENE SEQUENCES IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA. : ABSTRACT 36
TREATMENT OF RELAPSED/REFRACTORY AIDS-RELATED LYMPHOMAS (AIDS-NHL) WITH HIGH DOSE CYTARABINE(ARAC)/CISPLATIN COMBINATION REGIMENS : ABSTRACT 37
HIGH INCIDENCE OF NON-HOGKIN'S LYMPHOMA (NHL) IN HIV/HHV8 ASSOCIATED CASTLEMAN'S DISEASE (CD) : ABSTRACT 38
PROLIFERATION IN HHV-8 POSITIVE PRIMARY EFFUSION LYMPHOMAS IS ASSOCIATED WITH EXPRESSION OF HHV-8 CYCLIN BUT INDEPENDENT OF P27/KIP1 : ABSTRACT 39
PHARMACOLOGIC INDUCTION OF LYTIC INFECTION: A NOVEL THERAPEUTIC STRATEGY FOR EBV- AND KSHV-ASSOCIATED MALIGNANCIES : ABSTRACT 40
Kaposi's Sarcoma Herpes Virus (KSHV) Impairs antigen presentation in latently infected cells. : ABSTRACT 41
HUMAN HERPESVIRUS 8 OPEN READING FRAME K1 SIGNALS THROUGH NFχB AND ACTIVATES CELLS : ABSTRACT 42
WITHDRAWN : ABSTRACT 43
SIGNAL TRANSDUCTION PATHWAYS INVOLVED IN REACTIVATION OF HUMAN HERPESVIRUS 8 (HHV-8) IN LATENTLY-INFECTED CELLS: EVIDENCE FOR DISTINCT CALCINEURIN- AND PROTEIN KINASE C-DEPENDENT PATHWAYS. : ABSTRACT 44
NON-HODGKIN'S LYMPHOMA AMONG PEOPLE WITH AIDS: INCIDENCE AND ATTRIBUTABLE FRACTION IN ITALY. : ABSTRACT 45
LYMPHOID NEOPLASMS IN HIV POSITIVE INDIVIDUALS IN INDIA. : ABSTRACT 46
CHANGES IN AIDS-RELATED LYMPHOMA SINCE THE INTRODUCTION OF HAART : ABSTRACT 47
IMPACT OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) ON HIV-ASSOCATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) : ABSTRACT 48
QUANTITATION OF AIDS LYMPHOMA ASSOCIATED MACROPHAGE RNA: IMPLICATIONS FOR “SEQUENTIAL PATHOGENESIS” OF EXTRANODAL LYMPHOMA : ABSTRACT 49
IMMUNOGLOBULIN MUTATION PATTERN AND PHENOTYPIC PROFILE IN AIDS-RELATED DIFFUSE LARGE CELL LYMPHOMA: IMPLICATIONS FOR HISTOGENESIS : ABSTRACT 50
A Set of Mitochondrial Genes Overexpressed in AIDS-associated Human and Monkey B-cell Non-Hodgkin's Lymphomas Probably Contributes to Apoptosis Suppression and Malignant Transformation. : ABSTRACT 51
LYMPHOMAGENESIS IN A SIMIAN AIDS MODEL : ABSTRACT 52
Interferon Alpha Induces TRAIL, Cleavage Of FLICE And FADD Dependent Apoptosis In Primary Effusion Lymphoma. : ABSTRACT 53
Expression of BCL-6 and CD138/syndecan-1 in posttranplantation lymphoproliferative disorders. Correlation with Epstein-Barr virus detection. : ABSTRACT 54
MUTATIONS IN BALF1, A VBCL-2 OF EPSTEIN-BARR VIRUS, RESULT IN A PRO-APOPTOTIC MOLECULE THAT DOES NOT ASSOCIATE WITH BCL-2 : ABSTRACT 55
Establishment of an Epstein Barr Virus (EBV) Cytotoxic T Lymphocyte Bank for use in Adoptive T Cell Therapy : ABSTRACT 56
Dynamics of EBV burden in HIV-infected subjects under antiretroviral therapy. : ABSTRACT 57
The study on hepatitis C virus infection in maligent lymphocytic proliferation disease (MLPD) : ABSTRACT 58
LACK OF DIAGNOSTIC UTILITY OF BONE MARROW BIOPSY IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) RELATED NON-HODGKIN'S LYMPHOMA PRESENTING AS FEVER OF UNKNOWN ORIGIN (FUO). : ABSTRACT 59
MOBILIZATION OF PERIPHERAL BLOOD PROGENITOR CELLS (PBPC) AND ENGRAFTMENT FOLLOWING HIGH-DOSE CHEMOTHERAPY FOR AIDS-LYMPHOMA : ABSTRACT 60
LIPOSOMAL DAUNORUBICIN (DAUNOXOME) IN RELAPSED/ REFRACTORY AIDS-RELATED NON-HODGKIN'S LYMPHOMAS (AIDS-NHL). : ABSTRACT 61
MULTI-DRUG RESISTANCE (MDR-1) IN HIV SEROPOSITIVE PATIENTS WITH HODGKIN'S DISEASE : ABSTRACT 62
PHASE II TRIAL OF SEQUENTIAL CHEMOTHERAPY AND RADIOTHERAPY FOR AIDS-RELATED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) STUDY (E1493). : ABSTRACT 63
CLINICALLY UNSUSPECTED BONE MARROW PRESENTATION OF HODGKIN'S DISEASE IN AN HIV (+) PATIENT WITH PANCYTOPENIA. : ABSTRACT 64
Treatment Of HIV Associated Multicentric Castleman's Disease With Oral Etoposide. : ABSTRACT 65
Heat Shock Protein (HSP70)-Peptide Complex Induces Immunity In EG.7 Tumors: Potential Application As A Cervical Cancer Vaccine. : ABSTRACT 66
HIV INFECTION AND LUNG CANCER (LC). : ABSTRACT 67
Cutaneous Malignant Melanoma in five patients with HIV disease. : ABSTRACT 68
Protective role of Protein A in modulating zidovudine induced toxicity in mice. : ABSTRACT 69
CASE REPORT OF AN EXPLOSIVE COURSE OF PENILE CANCER IN AN AIDS PATIENT : ABSTRACT 70
CANCER CACHEXIA MASQUERADING AS HAART-ASSOCIATED FAT MALDISTRIBUTION SYNDROME (FMS). : ABSTRACT 71
CONDYLOMATA ACUMINATUM PRESENTING AS A DORSAL TONGUE LESION IN A PATIENT WITH AIDS. : ABSTRACT 72
VACUOLAR MYELOPATHY (VM). A LATE COMPLICATION OF AIDS IN A PATIENT WITH NHL. : ABSTRACT 73
ACUTE MYELOID LEUKEMIA (AML) IN A PATIENT WITH AIDS. WHAT DOES THE LITERATURE REVEAL? : ABSTRACT 74
ANGIOGENESIS INHIBITOR COL-3 IN THE TREATMENT OF HIV-RELATED KAPOSI'S SARCOMA: A PHASE I AIDS MALIGNANCY CONSORTIUM STUDY. : ABSTRACT 75
TREATMENT OF HUMAN PAPILLOMAVIRUS (HPV) TYPE 16 VIRUS-INFECTED CELLS USING THE HERPES SIMPLEX VIRUS THYMIDINE KINASE (HSV-TK) GENE : ABSTRACT 76
Detection of Human Polyomavirus JC (JCV) in Pediatric HIV-Associated Cancers. : ABSTRACT 77
SEROLOGICAL ASSAYS FOR KSHV BASED ON RECOMBINANT VIRAL PROTEINS : ABSTRACT 78
COMPARISON OF HHV-8 SEROLOGIC ASSAYS AND DEVELOPMENT OF AN ALGORITHM FOR HHV-8 SERODIAGNOSIS : ABSTRACT 79
A HIGHLY SENSITIVE AND SPECIFIC SEROLOGIC ASSAY FOR HHV-8 BASED ON SYNTHETIC PEPTIDES : ABSTRACT 80
SELECTION OF REFERENCE GROUPS AND CUT-POINTS IN THE DEVELOPMENT OF HHV-8 SEROLOGIC ASSAYS : ABSTRACT 81
SEROLOGICAL RESPONSES TO HHV-8 (KSHV). : ABSTRACT 82
SEROLOGIC ASSAYS FOR DETECTION OF HHV-8 ANTIBODIES : ABSTRACT 83
PERFORMANCE OF HHV-8 SEROLOGICAL ASSAYS FOR TESTING SERA FROM DIVERSE POPULATIONS : ABSTRACT 84
KSHV (HHV8) SEROLOGY IN EUROPE AND UGANDA: A MULTICENTRIC STUDY WITH MULTIPLE AND NOVEL ASSAYS : ABSTRACT 85
MULTICENTER COMPARISON OF HHV-8 SEROLOGIC ASSAYS AND ASSESSMENT OF HHV-8 SEROPREVALENCE IN US BLOOD DONORS : ABSTRACT 86